TITLE

Prevention, Diagnosis, and Treatment of Cervical Cancer

AUTHOR(S)
Long III, Harry J.; Laack, Nadia N. I.; Gostout, Bobbie S.
PUB. DATE
December 2007
SOURCE
Mayo Clinic Proceedings;Dec2007, Vol. 82 Issue 12, p1566
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
This article reviews the current data on human papillomavirus as the cause of most cervical cancer cases, data on the recently approved human papillomavirus vaccines, and updated information concerning the Bethesda System for Interpretation of Papanicolaou test results. Current recommendations for surgical treatment, concurrent chemotherapy, and radiation therapy and recent advances in systemic therapy for advanced or metastatic cervical cancer are reviewed.
ACCESSION #
27828564

 

Related Articles

  • Doubts on the appropriateness of universal human papillomavirus vaccination: is evidence on public health benefits already available? Porta, M.; González, B.; Márquez, S.; Artazcoz, I. // Journal of Epidemiology & Community Health;Aug2008, Vol. 62 Issue 8, p667 

    The article focuses on the doubts related to the suitability of the universal human papillomavirus (HPV) vaccination. The authors state that policy makers must rigorously evaluate the benefits of HPV vaccine before deciding on specific bills related to it. In Spain, there have ben doubts...

  • Cervarix PI updated.  // Australian Journal of Pharmacy;Aug2011, Vol. 92 Issue 1095, p48 

    The article offers information on the product information (PI) of the Cervarix human papillomavirus (HPV) vaccine, which was shown as highly effective against cervical pre-cancerous lesions caused by HPV types 16 and 18.

  • Cost-effectiveness of human papillomavirus vaccination for prevention of cervical cancer in Taiwan. Pang-Hsiang Liu; Fu-Chang Hu; Ping-Ing Lee; Song-Nan Chow; Chao-Wan Huang; Jung-Der Wang // BMC Health Services Research;2010, Vol. 10, Special section p1 

    Background: Human papillomavirus (HPV) infection has been shown to be a major risk factor for cervical cancer. Vaccines against HPV-16 and HPV-18 are highly effective in preventing type-specific HPV infections and related cervical lesions. There is, however, limited data available describing the...

  • Cancer vaccinations begin.  // Australian Nursing Journal;May2007, Vol. 14 Issue 10, p14 

    The article provides information on the National Human Papillomavirus Vaccination (HPV) program in Australia. The aim of the program is to vaccinate girls against cervical cancer. The government has provided $537 million for the program and the HPV vaccine is being provided through school-based...

  • A breakthrough in cervical cancer treatment. Saunders, Carol S. // Patient Care;1/30/2000, Vol. 34 Issue 2, p70 

    Reports on a landmark group of studies released by the National Cancer Institute which shows that adding chemotherapy to radiation can reduce mortality by half in patients with cervical cancer. Prevention programs and advances in human papillomavirus testing that aid in the management of the...

  • Who is Cancer Charlie, and how do we stop him?  // Contraceptive Technology Update;Sep2009, Vol. 30 Issue 9, p104 

    The article focuses on the safety issues and use of the vaccine Gardasil to prevent human papillamovirus (HPV) which causes cervical cancer to women.

  • Potential Health and Economic Impact of Adding a Human Papillomavirus Vaccine to Screening Programs. Kulasingam, Shalini L.; Myers, Evan R. // JAMA: Journal of the American Medical Association;8/13/2003, Vol. 290 Issue 6, p781 

    Context: Recently published results suggest that effective vaccines against cervical cancer—associated human papillomavirus (HPV) may become available within the next decade. Objective: To examine the potential health and economic effects of an HPV vaccine in a setting of existing...

  • Moving forward with HPV vaccination. Steinke, Leah // Infectious Disease News;Sep2013, Vol. 26 Issue 9, p24 

    The article reports on the greater need for Human papillomavirus (HPV) vaccination in the U.S. after it was found that HPV, particularly HPV-16 and HPV-18, was responsible for causing about 70 percent of all cervical cancers.

  • It's time for more public schools to join the fight against cervical cancer. Wellisch, Lawren D.; Brown, Benjamin P. // Infectious Diseases in Children;May2014, Vol. 27 Issue 5, p7 

    The article presents author's views regarding advantages of human papilloma virus (HPV) vaccine in reducing rate of cervical cancer.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics